Companies: 10,822     total market cap: โ‚ฌ125.489 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Alkermes
ALKS
#2743
Rank
โ‚ฌ5.37 B
Marketcap
๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Country
32,23ย โ‚ฌ
Share price
-2.29%
Change (1 day)
14.74%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

Revenue for Alkermes (ALKS)

Revenue in 2026 (TTM): โ‚ฌ1.33 Billion

According to Alkermes's latest financial reports the company's current revenue (TTM ) is โ‚ฌ1.34 Billion. In 2025 the company made a revenue of โ‚ฌ1.25 Billion a decrease over the revenue in the year 2024 that were of โ‚ฌ1.49 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Alkermes from 1996 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ1.33 B6.19%
2025 โ‚ฌ1.25 B-16.06%
2024 โ‚ฌ1.49 B-0.52%
2023 โ‚ฌ1.50 B45.18%
2022 โ‚ฌ1.03 B0%
2021 โ‚ฌ1.03 B22.72%
2020 โ‚ฌ0.84 B-19.21%
2019 โ‚ฌ1.04 B9.28%
2018 โ‚ฌ0.95 B27.05%
2017 โ‚ฌ0.75 B6.2%
2016 โ‚ฌ0.70 B23.37%
2015 โ‚ฌ0.57 B12.95%
2014 โ‚ฌ0.50 B
2012 โ‚ฌ0.41 B71.49%
2011 โ‚ฌ0.23 B82.88%
2010 โ‚ฌ0.13 B2.02%
2009 โ‚ฌ0.12 B-48.11%
2008 โ‚ฌ0.24 B48.35%
2007 โ‚ฌ0.16 B-3.95%
2006 โ‚ฌ0.17 B51.05%
2005 โ‚ฌ0.11 B125.1%
2004 โ‚ฌ50.99 M81.97%
2003 โ‚ฌ28.02 M-38.43%
2002 โ‚ฌ45.51 M-21.71%
2001 โ‚ฌ58.13 M22.99%
2000 โ‚ฌ47.26 M91.21%
1999 โ‚ฌ24.72 M-36.47%
1998 โ‚ฌ38.91 M64.99%
1997 โ‚ฌ23.58 M52.89%
1996 โ‚ฌ15.42 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ82.85 B 6,067.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ48.64 B 3,521.46%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ54.43 B 3,952.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ47.68 B 3,449.97%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚ฌ41.68 B 3,003.31%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ51.96 B 3,768.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
โ‚ฌ70.23 M-94.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
โ‚ฌ99.44 M-92.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ14.91 B 1,010.41%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com